APA (7th ed.) Citation

AS, S., AA, C., S, A., GS, C., PN, T., RM, D., . . . AH, H. (2026). Effect of glucagon-like peptide-1 agonists on deep inferior epigastric perforator flap breast reconstruction outcomes in obese patients: A study of 5618 patients. Journal of plastic, reconstructive & aesthetic surgery : JPRAS, 113, 194. https://doi.org/10.1016/j.bjps.2025.11.048

Chicago Style (17th ed.) Citation

AS, Sidhu, Chopra AA, Ahmed S, Corpuz GS, Towfighi PN, Danforth RM, Lester ME, and Hassanein AH. "Effect of Glucagon-like Peptide-1 Agonists on Deep Inferior Epigastric Perforator Flap Breast Reconstruction Outcomes in Obese Patients: A Study of 5618 Patients." Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS 113 (2026): 194. https://doi.org/10.1016/j.bjps.2025.11.048.

MLA (9th ed.) Citation

AS, Sidhu, et al. "Effect of Glucagon-like Peptide-1 Agonists on Deep Inferior Epigastric Perforator Flap Breast Reconstruction Outcomes in Obese Patients: A Study of 5618 Patients." Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS, vol. 113, 2026, p. 194, https://doi.org/10.1016/j.bjps.2025.11.048.